Eastern Iowa IA
Pfizer to buy Array BioPharma in deal worth $11.4 billion
NEW YORK - Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing posi…
